Migdal Insurance & Financial Holdings’s 10x Genomics TXG Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,670	Closed	-$845K	–	674
2021 Q1	$845K	Buy	4,670 +2,898	+164%	+$500K	0.01%	260
2020 Q4	$251K	Sell	1,772 -10,630	-86%	-$1.54M	﹤0.01%	291
2020 Q3	$1.55M	Sell	12,402 -10,747	-46%	-$1.13M	0.02%	223
2020 Q2	$2.07M	Buy	23,149 +7,552	+48%	+$588K	0.03%	179
2020 Q1	$972K	Buy	+15,597	New	+$1.22M	0.02%	182

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

MCAV

Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Migdal Insurance & Financial Holdings's TXG Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of 10x Genomics (TXG) in Q2 2021, closing a stake of 4,670 shares — an estimated $845K sold.

Migdal Insurance & Financial Holdings first reported a position in TXG in Q1 2020 and held it in 5 quarters. The position peaked at $2.07M in Q2 2020. 340 funds tracked by Wall St. Rank hold TXG as of Q2 2021.

Migdal Insurance & Financial Holdings reported no remaining 10x Genomics position as of Q2 2021 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 4,670 10x Genomics shares in Q2 2021, an estimated $845K.
Migdal Insurance & Financial Holdings first reported a position in 10x Genomics in Q1 2020 and held it in 5 quarters.
Migdal Insurance & Financial Holdings's 10x Genomics position peaked at $2.07M in Q2 2020.
340 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.